NCT01370603View on ClinicalTrials.gov

A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1)

PHASE3CompletedINTERVENTIONAL
Enrollment

328

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Hypercholesterolemia
Interventions
DRUG

Atorvastatin

40 mg tablet administered orally once daily

DRUG

Ezetimibe

10 mg tablet administered orally once daily

DRUG

Ezetimibe/atorvastatin

Ezetimibe/atorvastatin 10 mg/40 mg combination tablet administered orally once daily

DRUG

Placebo to atorvastatin

Administered orally once daily

DRUG

Placebo to ezetimibe

Administered orally once daily

DRUG

Placebo to ezetimibe/atorvastatin

Administered orally once daily

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT01370603 - A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1) | Biotech Hunter | Biotech Hunter